Amphastar Pharmaceuticals, Inc. - Common Stock — Balance Sheet (NASDAQ:AMPH) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 631.24 M671.53 M741.99 M1.51 B1.58 B1.63 B Total liabilities 182.51 M226.01 M213.33 M873.49 M845.17 M840.49 M Total equity 448.72 M445.52 M528.66 M639.42 M732.3 M788.8 M Total liabilities & shareholders' equities 631.24 M671.53 M741.99 M1.51 B1.58 B1.63 B Total debt 45.92 M78.19 M76.64 M603.17 M613.53 M619.71 M Net debt 45.92 M78.19 M76.64 M603.17 M613.53 M619.71 M

News

BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last?

Like My Stock Portfolio, My Bullish Options Portfolio Crushed The Benchmarks

Is CRMD Stock a Buy Now After Strong Growth and New Risks?

CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path

New Strong Sell Stocks for June 23rd

Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come (NYSE:EBS)

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow (NASDAQ:AMPH) 2026-06-03

Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right (NASDAQ:XERS)

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript

Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates